Dr Sulaiman Al Habib Medical Services (4013) Q4 2025 earnings summary

Executive summary

• Achieved strong revenue growth of 22.4% year-over-year, reaching 13,707 million, with net income up 3.7% to 2,401 million.

• Opened multiple new hospitals and medical centers, expanding geographic footprint and service capacity.

• Signed strategic partnerships and contracts for future hospital operations and management, supporting long-term growth.

• Maintained high patient volume, with a 27.5% increase to 9.5 million patients and 60% bed occupancy.

• Continued investment in technology, medical education, and ESG initiatives, earning multiple industry recognitions.

Financial highlights

• Revenue rose to 13,707 million from 11,200 million year-over-year; gross profit increased 12.4% to 4,207 million.

• EBITDA grew 17.9% to 3,507 million; EBITDA margin slightly decreased to 25.6%.

• Net income margin declined to 17.5% from 20.7% year-over-year.

• Cash from operations reached 3,402 million, with cash and equivalents at period end of 2,282 million.

• Dividend payout ratio remained high at 70.4%, with total dividends of 4.83 per share.

Outlook and guidance

• Robust expansion plans with several hospitals under construction and new management contracts signed for future projects.

• Focus on technology, operational efficiency, and service diversification to drive sustainable growth.